{"location": {"country": "US", "locality": "Summit", "region": "Summit", "postal_code": "07901", "street_address": null, "latitude": 40.71798, "longitude": -74.35874}, "salary": {"currency": null, "min_value": null, "max_value": null, "unit": null}, "job": {"title": "Research Scientist ", "industry": "Pharmaceuticals,Biotechnology", "description": "This role is with fortune 500 client:\nTitle:\u00a0Research Scientist\nDuration: 12 months\nJob id:\u00a041895-1\nLocation: SUMMIT, NJ\nJob Description:\nThe candidate will work with our translational development team and independently contribute to the development and execution of laboratory experiments to understand disease biology, drug resistance, mechanism of action of drugs and drug combinations. This will include working with lymphoma cell lines. The candidate should have enthusiasm for helping support laboratory programs, have knowledge of immunology, cell biology and signal transduction pathways and technical expertise in molecular and cellular based assays documented by relevant publications and work experience. They should also possess a strong understanding of the science behind ongoing experiments: the rationale, purpose and appropriate analytical methods to aid experimental design, troubleshooting and result interpretation.\nRequirements\n\u2022 PhD in Cellular or Molecular Biology, Cancer biology, Biochemistry, Genetics, or related fields with a minimum 2-3 years of post-Ph.D. experience.\n\u2022 Extensive knowledge about cancer biology, signal transduction and cancer epigenetics. Prior research with blood cancer field is a plus.\n\u2022 Expertise in general skills of molecular cell biology, such as Molecular Cloning, Primer design, RNA isolation, RT-PCR, Western Blotting, and basic cellular assays (e.g. proliferation/apoptosis).\n\u2022 Proficient with techniques used for epigenetic/transcriptional profiling including ChIP-seq, ATAC-seq, bulk RNA-seq and library preparation is a plus.\n\u2022 Experience with various genetic manipulation approaches including shRNA, RNAi, ectopic expression, and CRISPR based techniques is a plus.\n\u2022 Experience with flow cytometry is a plus.\n\u2022 Experience with PowerPoint, FlowJo and GraphPad Prism software.\n\u2022 Experience with C-bioportal and UCSC genome browser interfaces is a plus.\n\u2022 Communication and writing skills necessary to effectively convey data and interpretations with internal groups and at external meetings.\n\u2022 Problem solving skills to resolve technical issues.\n\u2022 Ability to manage time efficiently to meet project team deadlines and exhibit flexibility and adaptability to changing projects, work assignments and priorities.\nResponsibilities:\nThe candidate will provide laboratory support by means of data generation and analysis for clinical trial biomarker strategies, publications and internal study reports. Responsibilities will include:\n\u2022 Characterize and validate therapeutic targets identified from cancer genome project.\n\u2022 Generate stable cancer cell lines via lentiviral transduction.\n\u2022 Performing molecular and cell biological techniques including, flow cytometry, RNA isolation, qRT-PCR, Western blot, proliferation, cell cycle, apoptosis assays.\n\u2022 Performing epigenetic techniques including ChIP-qPCR, ChIP-seq and library preparation.\n\u2022 Performing in vitro testing of compounds to evaluate mechanisms of drug response and resistance. Developing rational drug combination strategies.\n\u2022 Detail-oriented. Keeping good experimental records. Being able to write detailed protocols.\n\u2022 Participating in translational team meetings by presenting data and providing interpretation of experimental results.\n\u2022 Helping to cultivate a positive and productive working relationship with colleagues.", "employment_type": "CONTRACTOR", "date_posted": "2021-10-05T17:31:50.000Z"}, "company": {"name": "Net2Source Inc.", "link": "https://www.linkedin.com/company/net2sourceinc"}, "education": {"required_credential": null}, "experience": {"months_of_experience": 24, "seniority_level": "Mid-Level"}}